Evidence map›Paper›PMID 41261402›Full record

ArticleAdvances in rheumatology (London, England)2025

Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"

Viviane Angelina de Souza, Ana Luiza Mendes Amorim Caparroz, Virginia Fernandes Moça Trevisani, Anna Carolina Faria Moreira Gomes Tavares, Ana Karla Guedes de Melo, Anete Trajman, Ana Cristina de Medeiros-Ribeiro, Marcelo de Medeiros Pinheiro, Ricardo Machado Xavier, Odirlei Andre Monticielo and 32 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in rheumatology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors.

Viviane Angelina de SouzaHospital Universitário da Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil. vivi.reumato@gmail.com.
Ana Luiza Mendes Amorim CaparrozFaculdade de Medicina de São José do Rio Preto, São José do Rio Preto, Brazil.
Virginia Fernandes Moça TrevisaniUniversidade de Santo Amaro UNISA, Santo Amaro, Brazil.
Anna Carolina Faria Moreira Gomes TavaresHospital das Clínicas - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Ana Karla Guedes de MeloHospital Universitário Lauro Wanderley - Universidade Federal da Paraíba, João Pessoa, Brazil.
Anete TrajmanUniversidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Ana Cristina de Medeiros-RibeiroHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Marcelo de Medeiros PinheiroUniversidade Federal de São Paulo (UNIFESP/ EPM), São Paulo, Brazil.
Ricardo Machado XavierHospital de Clínicas de Porto Alegre - Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Odirlei Andre MonticieloHospital de Clínicas de Porto Alegre - Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Maria Fernanda Brandão de Resende GuimarãesHospital das Clínicas - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Flavio SztajnbokUniversidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Sidney BombardaSecretaria de Estado da Saúde de São Paulo, São Paulo, Brazil.
Liliana Andrade ChebliHospital Universitário da Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
Adriana Maria KakehasiFaculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Ana Luiza BierrenbachInstituto de Ensino e Pesquisa - Hospital Sírio-Libanês, São Paulo, Brazil.
Ana Paula Monteiro Gomides ReisCentro Universitário de Brasília, Brasília, Brazil.
Blanca Elena Rios Gomes BicaUniversidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Claudia Diniz Lopes MarquesHospital das Clinicas - Universidade Federal de Pernambuco, Recife, Brazil.
Cristina FloresCentro de Tratamento de Doenças Inflamatórias Intestinais e Imunomediadas, Porto Alegre, Brazil.
Denise Silva RodriguesInstituto Clemente Ferreira - São Paulo, São Paulo, Brazil.
Eduardo Dos Santos PaivaHospital de Clinicas da Universidade Federal do Paraná, Curitiba, Brazil.
Eliana Dias MatosHospital Especializado Octávio Mangabeira (Bahia), Salvador, Brazil.
Fernanda Dockhorn Costa JohansenCoordenação-Geral de Vigilância da Tuberculose, Micoses Endêmicas e Micobactérias não Tuberculosas, (Ministério da Saúde), Brasília, Brazil.
Helio Arthur BachaHospital Israelita Albert Einstein, São Paulo, Brazil.
Joana Starling de CarvalhoHospital das Clínicas - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
José Roberto ProvenzaHospital Universitário da PUC Campinas, Campinas, Brazil.
Ketty Lysie Libardi Lira MachadoHospital Universitário Cassiano Antonio Moraes da Universidade Federal do Espírito Santo (UFES), Vitória, Brazil.
Licia Maria Henrique da MotaHospital Universitário de Brasília, Universidade de Brasília, Brasília, Brazil.
Lilian David de Azevedo ValadaresHospital Getulio Vargas de Pernambuco, Recife, Brazil.
Marco Antônio Araújo da Rocha LouresUniversidade Estadual de Maringá/UEM, Maringá, Brazil.
Margareth Maria Pretti DalcolmoCentro de Referência Professor Hélio Fraga - Fiocruz, Rio de Janeiro, Brazil.
Maria Cecilia de Carvalho BortolettoHospital Servidor Municipal São Paulo, São Paulo, Brazil.
Max Igor Banks Ferreira LopesHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Rejane Maria Rodrigues de Abreu VieiraUniversidade de Fortaleza (UNIFOR), Fortaleza, Brazil.
Ricardo RomitiHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Rogerio Saad-HossneFaculdade de Medicina de Botucatu - Universidade Estadual Paulista - UNESP, São Paulo, Brazil.
Rozana Mesquita CiconelliUniversidade Federal de São Paulo (UNIFESP/ EPM), São Paulo, Brazil.
Valderilio Feijó AzevedoHospital de Clinicas da Universidade Federal do Paraná, Curitiba, Brazil.
Valéria Maria AugustoHospital das Clínicas - Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Vitor Alves CruzUniversidade Federal de Goiás (UFG), Goiás, Brazil.
Gecilmara Cristina Salviato PileggiUniversidade Federal de São Paulo (UNIFESP/ EPM), São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In response to a letter addressing the Brazilian guidelines for tuberculosis infection (TBI) screening in immune-mediated inflammatory diseases (IMID), we clarify that the recommendations reflect a structured, evidence-based consensus developed by a multidisciplinary panel, in accordance with internationally accepted standards. We reaffirm the rationale for annual TBI retesting during the first three years of immunosuppressive therapy, particularly with TNF inhibitors, and the outweighed risk of tuberculosis preventive treatment (TPT), given the benefits. These recommendations are aligned with national and international public health policies and underscore the need for flexibility in clinical judgment. Nonetheless, they are conditional, reflecting the limited robustness of the available evidence. Continued dialogue is essential to ensure the safety and protection of IMID patients in high-burden settings like Brazil.

Indexed as

Latent TuberculosisPractice Guidelines as TopicBrazilHumansImmunosuppressive AgentsMass ScreeningImmunosuppressive Agents

Identifiers

PMID41261402
PMCPMC13488836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.